542 related articles for article (PubMed ID: 29562195)
1. Unconventional T Cell Targets for Cancer Immunotherapy.
Godfrey DI; Le Nours J; Andrews DM; Uldrich AP; Rossjohn J
Immunity; 2018 Mar; 48(3):453-473. PubMed ID: 29562195
[TBL] [Abstract][Full Text] [Related]
2. Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy.
Vigneron N; Abi Habib J; Van den Eynde BJ
Trends Cancer; 2017 Oct; 3(10):726-741. PubMed ID: 28958390
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
[TBL] [Abstract][Full Text] [Related]
4. The burgeoning family of unconventional T cells.
Godfrey DI; Uldrich AP; McCluskey J; Rossjohn J; Moody DB
Nat Immunol; 2015 Nov; 16(11):1114-23. PubMed ID: 26482978
[TBL] [Abstract][Full Text] [Related]
5. Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.
de Araújo ND; Gama FM; de Souza Barros M; Ribeiro TLP; Alves FS; Xabregas LA; Tarragô AM; Malheiro A; Costa AG
J Immunol Res; 2021; 2021():6633824. PubMed ID: 33506055
[TBL] [Abstract][Full Text] [Related]
6. Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
Kabelitz D; Wesch D; Pitters E; Zöller M
Int J Cancer; 2004 Dec; 112(5):727-32. PubMed ID: 15386388
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Tissue Resident Memory T Cells.
Mami-Chouaib F; Tartour E
Front Immunol; 2019; 10():1018. PubMed ID: 31191515
[No Abstract] [Full Text] [Related]
8. Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies.
Ngiow SF; Young A
Front Immunol; 2020; 11():1633. PubMed ID: 32849557
[TBL] [Abstract][Full Text] [Related]
9. Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.
Buckner JH; Nepom GT
J Autoimmun; 2016 Jul; 71():44-50. PubMed ID: 26948997
[TBL] [Abstract][Full Text] [Related]
10. TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity.
Stone JD; Harris DT; Kranz DM
Curr Opin Immunol; 2015 Apr; 33():16-22. PubMed ID: 25618219
[TBL] [Abstract][Full Text] [Related]
11. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
Paul S; Lal G
Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
[TBL] [Abstract][Full Text] [Related]
12. Unconventional T cells and kidney disease.
Kaminski H; Couzi L; Eberl M
Nat Rev Nephrol; 2021 Dec; 17(12):795-813. PubMed ID: 34446934
[TBL] [Abstract][Full Text] [Related]
13. Unconventional or Preset αβ T Cells: Evolutionarily Conserved Tissue-Resident T Cells Recognizing Nonpeptidic Ligands.
Legoux F; Salou M; Lantz O
Annu Rev Cell Dev Biol; 2017 Oct; 33():511-535. PubMed ID: 28661722
[TBL] [Abstract][Full Text] [Related]
14. Going back to class I: MHC and immunotherapies for childhood cancer.
Haworth KB; Leddon JL; Chen CY; Horwitz EM; Mackall CL; Cripe TP
Pediatr Blood Cancer; 2015 Apr; 62(4):571-6. PubMed ID: 25524394
[TBL] [Abstract][Full Text] [Related]
15. Early-life imprinting of unconventional T cells and tissue homeostasis.
Constantinides MG; Belkaid Y
Science; 2021 Dec; 374(6573):eabf0095. PubMed ID: 34882451
[TBL] [Abstract][Full Text] [Related]
16. Regulation and Functions of Protumoral Unconventional T Cells in Solid Tumors.
Barsac E; de Amat Herbozo C; Gonzalez L; Baranek T; Mallevaey T; Paget C
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298791
[TBL] [Abstract][Full Text] [Related]
17. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
18. Study May Change Approach to Immunotherapy.
Cancer Discov; 2016 May; 6(5):OF1. PubMed ID: 27012834
[TBL] [Abstract][Full Text] [Related]
19. Donor Unrestricted T Cells: A Shared Human T Cell Response.
Van Rhijn I; Moody DB
J Immunol; 2015 Sep; 195(5):1927-32. PubMed ID: 26297792
[TBL] [Abstract][Full Text] [Related]
20. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
